Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Stuttgart - Delayed Quote EUR

Apellis Pharmaceuticals Inc (1JK.SG)

Compare
16.61
-0.36
(-2.10%)
At close: April 15 at 9:34:46 PM GMT+2
Loading Chart for 1JK.SG
  • Previous Close 16.97
  • Open 16.83
  • Bid 16.78 x --
  • Ask 16.80 x --
  • Day's Range 16.61 - 16.83
  • 52 Week Range 16.45 - 48.99
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 1JK.SG

View More

Performance Overview: 1JK.SG

Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

1JK.SG
46.47%
S&P 500 (^GSPC)
8.25%

1-Year Return

1JK.SG
65.15%
S&P 500 (^GSPC)
6.61%

3-Year Return

1JK.SG
67.92%
S&P 500 (^GSPC)
22.86%

5-Year Return

1JK.SG
67.92%
S&P 500 (^GSPC)
93.89%

Compare To: 1JK.SG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 1JK.SG

View More

Valuation Measures

Annual
As of 4/14/2025
  • Market Cap

    2.14B

  • Enterprise Value

    2.19B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.05

  • Price/Book (mrq)

    10.57

  • Enterprise Value/Revenue

    3.18

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 1JK.SG

View More

Company Insights: 1JK.SG

Research Reports: 1JK.SG

View More